Improvement of Light Chain Proximal Tubulopathy without Crystals in IgG?-type Monoclonal Gammopathy of Undetermined Significance Using Bortezomib and Dexamethasone

被引:2
|
作者
Tsuyuki, Tomohisa [1 ]
Uramatsu, Tadashi [2 ]
Shimizu, Masatoshi [1 ]
Ishi, Takuma [1 ]
Tsuji, Kiyokazu [2 ]
Nakashima, Jun [3 ]
Katafuchi, Eisuke [4 ]
Nakayama, Toshiyuki [4 ]
Uesugi, Noriko [5 ]
Muta, Kumiko [1 ]
Nishino, Tomoya [1 ]
机构
[1] Nagasaki Univ Hosp, Dept Nephrol, Nagasaki, Japan
[2] JCHO Isahaya Gen Hosp, Dept Neurol, Isahaya, Japan
[3] JCHO Isahaya Gen Hosp, Dept Hematol, Isahaya, Japan
[4] Univ Occupat & Environm Hlth Sch, Dept Pathol, Kitakyushu, Japan
[5] Fukuoka Univ Hosp, Dept Pathol, Fukuoka, Japan
关键词
light chain proximal tubulopathy without crystals; monoclonal gammopathy of renal significance; monoclonal gammopathy of undetermined significance; paraprotein-related kidney disease; ADULT FANCONI-SYNDROME;
D O I
10.2169/internalmedicine.1835-23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 70 -year -old woman with acute kidney injury, a high serum Creatinine (Cr) level (3.91 mg/dL), and proteinuria (protein/Cr ratio 1.59 g/gCr) was admitted. Serum IgG ? -type and urinary ? -type M proteins were observed. A bone marrow examination indicated monoclonal gammopathy of undetermined significance (MGUS). A renal biopsy showed distended proximal tubular cells, and immunofluorescence identified tissue positive for proximal tubular cell ? light chains. Electron microscopy identified fibril-like structures in the lysosomes. The patient was diagnosed with light chain proximal tubulopathy without crystals in IgG ? -type MGUS and treated with bortezomib and dexamethasone therapy, which improved her renal function.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 50 条
  • [41] IgG Type Multiple Myeloma and Concurrent IgA Type Monoclonal Gammopathy of Undetermined Significance Complicated by Necrotizing Skin Ulcers due to Type I Cryoglobulinemia
    Ninomiya, Soranobu
    Fukuno, Kenji
    Kanemura, Nobuhiro
    Goto, Naoe
    Kasahara, Senji
    Yamada, Toshiki
    Tsurumi, Hisashi
    Moriwaki, Hisataka
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2010, 50 (01) : 71 - 74
  • [42] Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
    Dispenzieri, Angela
    Katzmann, Jerry A.
    Kyle, Robert A.
    Larson, Dirk R.
    Melton, L. Joseph, III
    Colby, Colin L.
    Therneau, Terry M.
    Clark, Raynell
    Kumar, Shaji K.
    Bradwell, Arthur
    Fonseca, Rafael
    Jelinek, D. F.
    Rajkumar, S. Vincent
    LANCET, 2010, 375 (9727): : 1721 - 1728
  • [43] Evaluating Diagnostic Performance of Light Chain Dimerization By Mass Spectrometry to Distinguish between AL Amyloidosis and Monoclonal Gammopathy of Undetermined Significance
    Loncharich, Alexa
    Fiala, Mark
    Fortier, Julie
    Stockerl-Goldstein, Keith
    Vij, Ravi
    Schroeder, Mark A.
    Zaydman, Mark
    Slade, Michael
    Liyasova, Mariya
    BLOOD, 2024, 144 : 1921 - 1922
  • [44] Isotype-Specific Heavy/Light Chain (HLC) Suppression as a Predictor of Myeloma Development in Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Katzmann, Jerry
    Clark, Raynell
    Dispenzieri, Angela
    Kyle, Robert
    Landgren, Ola
    Bradwell, Arthur
    Rajkumar, S. Vincent
    BLOOD, 2009, 114 (22) : 711 - 711
  • [45] ASSOCIATION OF SERUM HEAVY/LIGHT CHAIN PAIR SUPPRESSION WITH RISK FACTORS FOR PROGRESSION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SMOLDERING MYELOMA
    Isola, I.
    Sanz, M. T.
    Cibeira, M. T.
    Rosinol, L.
    Lozano, E.
    Arostegui, J. I.
    Elena, M.
    Tovar, N.
    Yague, J.
    Moga, E.
    Blade, J.
    Fernandez de Larrea, C.
    HAEMATOLOGICA, 2017, 102 : 777 - 778
  • [46] Renal Fanconi syndrome as a cause of chronic kidney disease in patients with monoclonal gammopathy of undetermined significance: partially reversed renal function by high-dose dexamethasone with bortezomib
    Nishida, Yuki
    Iwama, Kan-ichi
    Yamakura, Masayuki
    Takeuchi, Masami
    Matsue, Kosei
    LEUKEMIA & LYMPHOMA, 2012, 53 (09) : 1804 - 1806
  • [47] Association of kappa light chain restriction with peripheral neuropathy among patients with non-IgM monoclonal gammopathy of undetermined significance.
    Dasanu, Constantin A.
    Kaur, Jaspreet
    Tuler, Shahaf
    Farrell, Stephanie
    Plaxe, Steven C.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Increased prevalence of light chain monoclonal gammopathy of undetermined significance (MGUS) in first-degree relatives of individuals with multiple myeloma or MGUS
    Greenberg, Alexandra J.
    Rajkumar, S. Vincent
    Larson, Dirk R.
    Dispenzieri, Angela
    Therneau, Terry M.
    Colby, Colin L.
    Phelps, Tara K.
    Kumar, Shaji K.
    Katzmann, Jerry A.
    Kyle, Robert A.
    Slager, Susan L.
    Vachon, Celine M.
    CANCER RESEARCH, 2012, 72
  • [49] LIGHT CHAIN PROXIMAL TUBULOPATHY WITHOUT CRYSTALS IN A CASE OF NEWLY DIAGNOSED MULTIPLE MYELOMA PRESENTING WITH WORSENING CHRONIC KIDNEY DISEASE
    Ngo, J.
    Kirwan, P.
    Hughes, L.
    Gasiorowski, R.
    Ritchie, A.
    Sen, S.
    NEPHROLOGY, 2020, 25 : 59 - 59
  • [50] Investigation of the cardiotoxicity of full-length light chains derived from patients with cardiac light chain amyloidosis, multiple myeloma and monoclonal gammopathy of undetermined significance
    Nikolaou, Panagiota Efstathia
    Georgoulis, Anastasios
    Liacos, Christine
    Efentakis, Panagiotis
    Baltatzis, George
    Makridakis, Manousos
    Mavroidi, Barbara
    Pelecanou, Maria
    Vlachou, Antonia
    Terpos, Evangelos
    Vorgias, Constantinos E.
    Dimopoulos, Meletios Athanasios
    Kastritis, Efstathios
    Andreadou, Ioanna
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S153 - S153